← Back to Search

Screening Methods for Swallowing Disorders

N/A
Recruiting
Led By Oliver Acosta, MD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 20 minutes
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying ways to check for swallowing problems in stroke patients. It focuses on people who have had a stroke because they often have trouble swallowing. The tests help doctors find out if these patients are at risk of health issues from swallowing difficulties.

Who is the study for?
This trial is for adults aged 18-80 who've had an ischemic stroke within the last month and are at Lynn Rehabilitation Center. They must understand English or Spanish, be able to consent (or have a proxy do so), and not have a history of swallowing issues or certain brain injuries.
What is being tested?
The study compares two tests for dysphagia after an ischemic stroke: one is a non-standardized clinical evaluation, and the other uses the Mann Assessment of Swallowing Ability. It aims to identify which better detects swallowing difficulties and aspiration risk.
What are the potential side effects?
Since this trial involves screening tools rather than medications, there are no direct side effects from interventions. However, discomfort during swallow evaluations may occur.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 20 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Deglutition Disorders

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Group I: Non-standardized clinical swallow evaluation GroupExperimental Treatment1 Intervention
Participants in this group will receive standard of care treatment (dysphagia screening once upon admission to inpatient rehabilitation using a non-standardized clinical swallow evaluation for approximately 15 minutes).
Group II: Mann Assessment of Swallowing Ability (MASA) GroupExperimental Treatment1 Intervention
Participants in this group will receive the MASA dysphagia screening once upon admission to inpatient rehabilitation for approximately 20 minutes.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for swallowing difficulty include dietary modifications, swallowing therapy, and medical or surgical interventions. Dietary modifications involve altering food texture and consistency to make swallowing safer and easier. Swallowing therapy, often conducted by speech-language pathologists, focuses on exercises and techniques to strengthen the muscles involved in swallowing and improve coordination. Medical interventions may include medications to manage underlying conditions, while surgical options can address structural abnormalities. These treatments are crucial for dysphagia patients as they help prevent aspiration, improve nutritional intake, and enhance overall quality of life. Accurate screening tests for dysphagia and aspiration risk are essential to tailor these treatments effectively and ensure patient safety.

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor
948 Previous Clinical Trials
427,720 Total Patients Enrolled
Oliver Acosta, MDPrincipal InvestigatorUniversity of Miami
Gemayaret Alvarez, MDPrincipal InvestigatorUniversity of Miami

Media Library

Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool) Clinical Trial Eligibility Overview. Trial Name: NCT05603897 — N/A
Swallowing Difficulty Research Study Groups: Mann Assessment of Swallowing Ability (MASA) Group, Non-standardized clinical swallow evaluation Group
Swallowing Difficulty Clinical Trial 2023: Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool) Highlights & Side Effects. Trial Name: NCT05603897 — N/A
Mann Assessment of Swallowing Ability (MASA) (dysphagia screening tool) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05603897 — N/A
~6 spots leftby Jan 2025